Search This Blog

Thursday, August 1, 2019

Intellia Therapeutics EPS beats by $0.05, beats on revenue

Intellia Therapeutics (NASDAQ:NTLA): Q2 GAAP EPS of -$0.56 beats by $0.05.
Revenue of $11.12M (+44.8% Y/Y) beats by $3.97M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)